Company: NMP
Filing Date: 2025-06-12
Form Type: S-1/A
Source: 0001213900-25-053533
Chunk: 308

Company: NMP Acquisition Corp.
Filing Date: 2025-06-12
Form: S-1/A
Chunk 308
---
 13, 2025 at approximately $0.0065 per share. Prior to this offering, our sponsor may transfer founder shares, to our three independent director nominees for their board service, for nominal cash consideration. The number of founder shares issued was determined based on the expectation that the founder shares would represent 25% of the outstanding ordinary shares upon completion of this offering (excluding the representative shares and the private placement shares underlying the private placement units and any units that the initial shareholders may purchase in this offering). Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D, or otherwise subject to an exemption from the registration of the sale of securities under the Securities Act. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. On June [•], 2025, our sponsor forfeited 335,000 founder shares and certain individuals who are registered persons of Maxim Group LLC (“Maxim”), the representative of the underwriters, purchased 335,000 founder shares for an aggregate purchase price of approximately $[•], or approximately $[•] per share, which resulted in our sponsor owning 3,498,333 founder shares.

II-1

In addition, our sponsor and the Maxim individuals have committed, pursuant to written agreements, to purchase an aggregate of 80,000 private placement units for an aggregate purchase price of $800,000 (whether or not the underwriters’ over -allotmentoption is exercised). Of those 80,000 private placement units, our sponsor has agreed to purchase 57,500 private placement units and the Maxim individuals have agreed to purchase 22,500 private placement units. These purchases will take place on a private placement basis simultaneously with the completion of our initial public offering. These issuances will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid or will be paid with respect to such sales. Item 16. Exhibits and Financial Statement Schedules. (a)The following exhibits are filed as part of this Registration Statement:

| Exhibit No. |     | Description                                                                                                              |
| 1.1*        |     | Form of Underwriting Agreement                                                                                           |
| 3.1**       |     | Memorandum and Articles of Association                                                                                   |
| 3.2**       |     | Form of Amended and Restated Memorandum and Articles of Association